Works matching IS 1748717X AND DT 2017 AND VI 12 AND IP 1


Results: 8
    1

    Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation.

    Published in:
    2017
    By:
    • Geara, Fady B.;
    • Bulbul, Muhammad;
    • Khauli, Raja B.;
    • Andraos, Therese Y.;
    • Abboud, Mirna;
    • Al Mousa, Abdelatif;
    • Sarhan, Nasim;
    • Salem, Ahmed;
    • Ghatasheh, Hamza;
    • Alnsour, Anoud;
    • Ayoub, Zeina;
    • Gheida, Ibrahim Abu;
    • Charafeddine, Maya;
    • Shahait, Mohammed;
    • Shamseddine, Ali;
    • Gheida, Rami Abu;
    • Khader, Jamal
    Publication type:
    journal article
    2
    3
    4
    5
    6

    Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.

    Published in:
    2017
    By:
    • Jiang, Ping;
    • Krockenberger, Katja;
    • Vonthein, Reinhard;
    • Tereszczuk, Jane;
    • Schreiber, Arne;
    • Liebau, Sebastian;
    • Huttenlocher, Stefan;
    • Imhoff, Detlef;
    • Balermpas, Panagiotis;
    • Keller, Christian;
    • Dellas, Kathrin;
    • Baumann, Rene;
    • Rödel, Claus;
    • Hildebrandt, Guido;
    • Jünemann, Klaus-Peter;
    • Merseburger, Alex;
    • Katz, Alan;
    • Ziegler, Andreas;
    • Blanck, Oliver;
    • Dunst, Jürgen
    Publication type:
    journal article
    7
    8